436 related articles for article (PubMed ID: 15851853)
21. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
[TBL] [Abstract][Full Text] [Related]
23. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
Attems J; Jellinger KA
Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
[TBL] [Abstract][Full Text] [Related]
24. "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?
Abner EL; Kryscio RJ; Schmitt FA; Santacruz KS; Jicha GA; Lin Y; Neltner JM; Smith CD; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2011; 25(3):445-53. PubMed ID: 21471646
[TBL] [Abstract][Full Text] [Related]
25. The unfolded protein response is activated in the olfactory system in Alzheimer's disease.
Murray HC; Dieriks BV; Swanson MEV; Anekal PV; Turner C; Faull RLM; Belluscio L; Koretsky A; Curtis MA
Acta Neuropathol Commun; 2020 Jul; 8(1):109. PubMed ID: 32665027
[TBL] [Abstract][Full Text] [Related]
26. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's-related changes in non-demented essential tremor patients vs. controls: links between tau and tremor?
Pan JJ; Lee M; Honig LS; Vonsattel JP; Faust PL; Louis ED
Parkinsonism Relat Disord; 2014 Jun; 20(6):655-8. PubMed ID: 24679899
[TBL] [Abstract][Full Text] [Related]
28. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.
Serrano-Pozo A; Qian J; Muzikansky A; Monsell SE; Montine TJ; Frosch MP; Betensky RA; Hyman BT
J Neuropathol Exp Neurol; 2016 Jun; 75(6):516-26. PubMed ID: 27105663
[TBL] [Abstract][Full Text] [Related]
29. Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.
Wharton SB; Minett T; Drew D; Forster G; Matthews F; Brayne C; Ince PG;
Acta Neuropathol Commun; 2016 Feb; 4():11. PubMed ID: 26857919
[TBL] [Abstract][Full Text] [Related]
30. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease-related plaques in nondemented subjects.
Elobeid A; Rantakömi S; Soininen H; Alafuzoff I
Alzheimers Dement; 2014 Sep; 10(5):522-9. PubMed ID: 24742915
[TBL] [Abstract][Full Text] [Related]
32. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
33. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
[TBL] [Abstract][Full Text] [Related]
34. Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment.
Tremblay C; Serrano GE; Intorcia AJ; Mariner MR; Sue LI; Arce RA; Atri A; Adler CH; Belden CM; Shill HA; Driver-Dunckley E; Mehta SH; Beach TG
J Neuropathol Exp Neurol; 2022 Jul; 81(8):643-649. PubMed ID: 35751438
[TBL] [Abstract][Full Text] [Related]
35. The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities and neuropsychiatric symptoms.
Malpas CB; Sharmin S; Kalincik T
Int J Neurosci; 2021 Aug; 131(8):800-809. PubMed ID: 32303140
[TBL] [Abstract][Full Text] [Related]
36. Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
Beach TG; Sue LI; Walker DG; Sabbagh MN; Serrano G; Dugger BN; Mariner M; Yantos K; Henry-Watson J; Chiarolanza G; Hidalgo JA; Souders L
J Alzheimers Dis; 2012; 28(4):869-76. PubMed ID: 22112552
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
[TBL] [Abstract][Full Text] [Related]
38. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
39. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
[TBL] [Abstract][Full Text] [Related]
40. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
